Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana Reeve Foundation, a non-profit ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

The in-licensed antibody represents what iBio believes to be the first functional inhibitor of Activin E, a challenging, yet genetically validated therapeutic target playing a key role in regulating ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...

I remember he said it like a fact. Calmly — an if-then statement. To my teenage ears, it didn’t sound like a threat. Paul ...

Turpentine Market. The turpentine market is poised for steady growth, with sales projected to expand at a compound annual ...

It’s just PART of what makes him who he is … there’s a big difference!” Dax is the son of Hardin Valley Academy head football ...

New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the ...

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses ...

The microbiology culture market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving growth ...